Open Access
| Issue |
BIO Web Conf.
Volume 148, 2024
International Conference of Biological, Environment, Agriculture, and Food (ICoBEAF 2024)
|
|
|---|---|---|
| Article Number | 04003 | |
| Number of page(s) | 11 | |
| Section | Food | |
| DOI | https://doi.org/10.1051/bioconf/202414804003 | |
| Published online | 09 January 2025 | |
- Y. Yano, T. Utsumi, M.I. Lusida, and Y. Hayashi, Hepatitis B virus infection in Indonesia. World J. Gastroenterol 21, 10714 (2015) [CrossRef] [PubMed] [Google Scholar]
- Z. Abbas and A.R. Siddiqui, Management of hepatitis B in developing countries. World J. Hepatol. 3, 292 (2011) [CrossRef] [Google Scholar]
- B.J. Mcmahon, The natural history of chronic hepatitis B virus infection. Hepatol. 49, S45 (2009) [CrossRef] [PubMed] [Google Scholar]
- F.J. Mahoney, Update on diagnosis, management, and prevention of hepatitis B virus infection. Clin. Microbiol. Rev. 12, (1999) [Google Scholar]
- D. Yulia, Virus hepatitis B ditinjau dari aspek laboratorium. J. Kesehat. Andalas 8, 247 (2019) [Google Scholar]
- M. Belopolskaya, M. Belopolskaya, V. Avrutin, O. Kalinina, A. Dmitriev, and D. Gusev, Chronic hepatitis B in pregnant women: Current trends and approaches. World J. of Gastroenterol. 27, 3279 (2021) [CrossRef] [PubMed] [Google Scholar]
- T.J. Liang, Hepatitis B: The virus and disease. Hepatol. 49, (2009) [Google Scholar]
- M. Jefferies, B. Rauff, H. Rashid, T. Lam, and S. Rafiq, Update on global epidemiology of viral hepatitis and preventive strategies. World J. Clin. Cases. 6, 589 (2018) [CrossRef] [Google Scholar]
- L.M. Irham et al., The use of genomic variants to drive drug repurposing for chronic hepatitis B. Biochem. Biophys. Rep. 31, 101307 (2022) [Google Scholar]
- E.D. Green and M.S. Guyer, Charting a course for genomic medicine from base pairs to bedside. Nat. 470, 204 (2011) [CrossRef] [PubMed] [Google Scholar]
- L.M. Irham et al., The use of genomic variants to drive drug repurposing for chronic hepatitis B. Biochem. Biophys. Rep. 31, 101307 (2022) [Google Scholar]
- L.M. Irham et al., Evaluation for the genetic association between store-operated calcium influx pathway (Stim1 and orai1) and human hepatocellular carcinoma in patients with chronic hepatitis b infection. Biol. (Basel) 9, 1 (2020) [Google Scholar]
- D. Sun, W. Gao, H. Hu, and S. Zhou, Why 90% of clinical drug development fails and how to improve it?. Acta Pharm. Sinica B 12, 3049 (2022) [CrossRef] [Google Scholar]
- S.M. Paul et al., How to improve RD productivity: The pharmaceutical industry’s grand challenge. Nat. Rev. Drug. Discov. 9, 203 (2010) [CrossRef] [PubMed] [Google Scholar]
- S. Pushpakom et al., Drug repurposing: Progress, challenges and recommendations. Nat. Rev. Drug Discov. 18, 41 (2018) [Google Scholar]
- T.T. Ashburn and K.B. Thor, Drug repositioning: Identifying and developing new uses for existing drugs. Nat. Rev. Drug Discov. 3, 673 (2004) [CrossRef] [PubMed] [Google Scholar]
- M. Akmal et al., Glioblastome Multiforme: A Bibliometric Analysis. World. Neurosurg. 136, 270 (2020) [CrossRef] [Google Scholar]
- J.S. Brandt, O. Hadaya, M. Schuster, T. Rosen, M.V. Sauer, and C.V. Ananth, A Bibliometric Analysis of Top-Cited Journal Articles in Obstetrics and Gynecology. JAMA Netw Open 2, E1918007 (2019) [Google Scholar]
- M.E. Falagas, E.I. Pitsouni, G.A. Malietzis, and G. Pappas, Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses. The FASEB J. 22, 338 (2008) [Google Scholar]
- J.E. Hirsch, An index to quantify an individual’s scientific research output. Phys. Sci. 102, 16569 (2005) [Google Scholar]
- N.J. van Eck and L. Waltman, Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometr. 84, 523 (2010) [CrossRef] [PubMed] [Google Scholar]
- M. Aria and C. Cuccurullo, bibliometrix: An R-tool for comprehensive science mapping analysis. J. Informetr. 11, 959 (2017) [CrossRef] [Google Scholar]
- M. Wang et al., Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell. Res. 30, 269 (2020) [CrossRef] [PubMed] [Google Scholar]
- L.P. Jordheim, D. Durantel, F. Zoulim, and C. Dumontet, Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases. Nat. Rev. Drug Discov. 12, 447 (2013) [CrossRef] [PubMed] [Google Scholar]
- C. Tschöpe et al., Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat. Rev. Cardiol. 18, 169 (2021) [CrossRef] [PubMed] [Google Scholar]
- K. Xu, S. Yu, Z. Wang, Z. Zhang, and Z. Zhang, Bibliometric and visualized analysis of 3D printing bioink in bone tissue engineering. Front. in Bioeng. and Biotech. 11, (2023) [Google Scholar]
- J.J. Prieto-Gutiérrez and F. Segado-Boj, Annals of library and information studies: A bibliometric analysis of the journal and a comparison with the top library and information studies journals in Asia and Worldwide (2011-2017). Ser. Librarian 77, 38 (2019) [CrossRef] [Google Scholar]
- W.M. Sweileh, A.S. AbuTaha, A.F. Sawalha, S. Al-Khalil, S.W. Al-Jabi, and S.H. Zyoud, Bibliometric analysis of worldwide publications on multi-, extensively, and totally drug - resistant tuberculosis (2006-2015). Multidiscip. Respir. Med. 11, 1 (2017) [CrossRef] [Google Scholar]
- L.M. Irham et al., Investigation of susceptibility genes for chickenpox disease across multiple continents. Biochem. Biophys. Rep. 33, 101419 (2023) [Google Scholar]
- W. Adikusuma et al., Integrated genomic network analysis revealed potential of a druggable target for hemorrhoid treatment. Saudi Pharm. J. 31, 101831 (2023) [CrossRef] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.